Yonsei medical journal
-
While digital health solutions have shown good outcomes in numerous studies, the adoption of digital health solutions in clinical practice faces numerous challenges. To prepare for widespread adoption of digital health, stakeholders in digital health will need to establish an objective evaluation process, consider uncertainty through critical evaluation, be aware of inequity, and consider patient engagement. By "making friends" with digital health, health care can be improved for patients.
-
Yonsei medical journal · Jan 2022
Meta AnalysisArtificial Intelligence for Detection of Cardiovascular-Related Diseases from Wearable Devices: A Systematic Review and Meta-Analysis.
Several artificial intelligence (AI) models for the detection and prediction of cardiovascular-related diseases, including arrhythmias, diabetes, and sleep apnea, have been reported. This systematic review and meta-analysis aimed to identify AI models developed for or applicable to wearable and mobile devices for diverse cardiovascular-related diseases. ⋯ This review found that AI models for diverse cardiovascular-related diseases are being developed, and that they are gradually developing into a form that is suitable for wearable and mobile devices.
-
Yonsei medical journal · Jan 2022
Digital Dermatopathology and Its Application to Mohs Micrographic Surgery.
Digital pathology is being gradually adopted in hospitals due to technological advances. We propose that digital pathology can be used in Mohs micrographic surgery (Mohs surgery) to precisely check residual tumor cells in frozen tumor margin tissues. This would aid surgeons and pathologists in accurately recording tumor margins and give patients the benefit of shorter operation time.
-
Yonsei medical journal · Jan 2022
Gut Microbiome in Probable Intestinal Tuberculosis and Changes following Anti-Tuberculosis Treatment.
Information on the gut microbiome in patients with intestinal tuberculosis (ITB) and changes therein following anti-tuberculosis treatment (ATT) is lacking. We aimed to elucidate differences in stool microbiome between ITB patients and controls and to evaluate stool microbiome changes after ATT. ⋯ There were no significant differences in alpha- and beta-diversity in the stool microbiome at 0, 2, and 6 months after ATT. The stool microbiome composition of probable ITB patients was different from that of controls, and 6 months of ATT did not significantly affect it.
-
Yonsei medical journal · Jan 2022
Survey for Government Policies Regarding Strategies for the Commercialization and Globalization of Digital Therapeutics.
This study was conducted to build a direction for government policies regarding strategies for the commercialization of digital therapeutics in Korea, as well as its globalization. ⋯ For the digital therapeutics industry to evolve domestically and internationally, government support and guidance are essential.